Form 8-K - Current report:
SEC Accession No. 0001104659-25-039013
Filing Date
2025-04-25
Accepted
2025-04-25 07:18:25
Documents
15
Period of Report
2025-04-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513134d1_8k.htm   iXBRL 8-K 27405
2 EXHIBIT 99.1 tm2513134d1_ex99-1.htm EX-99.1 41952
6 GRAPHIC tm2513134d1_ex99-1img001.jpg GRAPHIC 23347
  Complete submission text file 0001104659-25-039013.txt   286180

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA irwd-20250425.xsd EX-101.SCH 3032
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20250425_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20250425_pre.xml EX-101.PRE 22370
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2513134d1_8k_htm.xml XML 3686
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 25869968
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)